1. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363-1372. PMID:
14594906.
2. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144. PMID:
1884444.
3. Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2003;2:439-447. PMID:
12776219.
4. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 1996;36:233-252. PMID:
8725389.
5. Yap YG, Camm AJ. The current cardiac safety situation with antihistamines. Clin Exp Allergy 1999;29(Suppl 1):15-24. PMID:
10209701.
7. Brown AM. Drugs, hERG and sudden death. Cell Calcium 2004;35:543-547. PMID:
15110144.
8. Ahmad SR. Adverse drug event monitoring at the food and drug administration. J Gen Intern Med 2003;18:57-60. PMID:
12534765.
9. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003;12:17-29. PMID:
12616844.
10. Weaver J, Bonnel RA, Karwoski CB, Brinker AD, Beitz J. GI events leading to death in association with celecoxib and rofecoxib. Am J Gastroenterol 2001;96:3449-3450. PMID:
11774975.
11. DesRoches CM, Campbell EG, Rao SR, Donelan K, Ferris TG, Jha A, Kaushal R, Levy DE, Rosenbaum S, Shields AE, Blumenthal D. Electronic health records in ambulatory care: a national survey of physicians. N Engl J Med 2008;359:50-60. PMID:
18565855.
12. Park RW, Shin SS, Choi Yl, Ahn JO, Hwang SC. Computerized physician order entry and electronic medical record systems in Korean teaching and general hospitals: results of a 2004 survey. J Am Med Inform Assoc 2005;12:642-647. PMID:
16049229.
13. Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: the need for a balanced perspective. Drug Saf 2005;28:835-842. PMID:
16180934.
14. Dewitt JG, Hampton PM. Development of a data warehouse at an academic health system: knowing a place for the first time. Acad Med 2005;80:1019-1025. PMID:
16249300.
15. Zhang Q, Matsumura Y, Teratani T, Yoshimoto S, Mineno T, Nakagawa K, Nagahama M, Kuwata S, Takeda H. The application of an institutional clinical data warehouse to the assessment of adverse drug reactions (ADRs): evaluation of aminoglycoside and cephalosporin associated nephrotoxicity. Methods Inf Med 2007;46:516-522. PMID:
17938772.
16. Szirbik NB, Pelletier C, Chaussalet T. Six methodological steps to build medical data warehouses for research. Int J Med Inform 2006;75:683-691. PMID:
16762589.
17. Sheen SS, Choi JE, Park RW, Kim EY, Lee YH, Kang UG. Overdose rate of drugs requiring renal dose adjustment: data analysis of 4 years prescriptions at a tertiary teaching hospital. J Gen Intern Med 2008;23:423-428. PMID:
18373140.
18. Hinrichsen VL, Kruskal B, O'Brien MA, Lieu TA, Platt R. Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc 2007;14:731-735. PMID:
17712091.
19. Akita M, Shibazaki Y, Izumi M, Hiratsuka K, Sakai T, Kurosawa T, Shindo Y. Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia. J Toxicol Sci 2004;29:63-71. PMID:
15018156.
20. Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine. Ann Pharmacother 2005;39:543-546. PMID:
15687478.
21. Gandhi PJ, Menezes PA, Vu HT, Rivera AL, Ramaswamy K. Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient. Am J Health Syst Pharm 2003;60:2479-2483. PMID:
14686224.
22. Taubel J, Naseem A, Harada T, Wang D, Arezina R, Lorch U, Camm AJ. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers. Br J Clin Pharmacol 2010;69:391-400. PMID:
20406223.
23. Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF. Effects of three fluoroquinolones on QT analysis after standard treatment courses. Ann Noninvasive Electrocardiol 2006;11:52-56. PMID:
16472283.
24. Park MY, Lee YH, Kim EY, Kim WJ, Kam HJ, Choi JP, Han TH, Kang UG, Park RW. A data warehouse based retrospective post-marketing surveillance method: a feasibility test with fluoxetine. J Korean Soc Med Inform 2009;15:191-199.
25. Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol 1920;53:320-339. PMID:
16993419.
26. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999;354:1625-1633. PMID:
10560690.
27. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of hypothermia. Am J Emerg Med 2002;20:314-326. PMID:
12098179.
28. Singh K. Effect of smoking on QT interval, QT dispersion and rate pressure product. Indian Heart J 2004;56:140-142. PMID:
15377136.
29. Suzuki M, Nishizaki M, Arita M, Ashikaga T, Yamawake N, Kakuta T, Numano F, Hiraoka M. Increased QT dispersion in patients with vasospastic angina. Circulation 1998;98:435-440. PMID:
9714094.
30. Radhakrishnan M, Agarwal S, Bithal PK, Gupta V. Heparin-induced transient prolongation of the QT interval during endovascular embolisation of intracranial aneurysm. J Clin Neurosci 2006;13:489-492. PMID:
16678734.